engleski

Liposomes for the treatment of vaginal infections

Vaginal administration of antifungal agents using conventional dosage forms can be limited by their residence time at the site of action. In addition, intravaginal route often leads to systemic insted of desired localized effect due to remarkable absorption from the vaginal mucosa. To overcome these problems, liposomes were suggested as a biocompatible drug formulation which could effectively deliver entrapped drug during an extended period of time. This presentation is focused on development of liposomes containing antifunal drugs and investigation of their stability in the presence of vaginal mucosa.

Liposomes; Preparation; Stability; Vaginitis

nije evidentirano